title: Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia.
authors.affiliation: Department of Medicine, University Hospital, Uppsala, Sweden.
authors.forename: B
authors.initials: B
authors.lastname: Simonsson
authors.forename: G
authors.initials: G
authors.lastname: Oberg
authors.forename: M
authors.initials: M
authors.lastname: Björeman
authors.forename: M
authors.initials: M
authors.lastname: Björkholm
authors.forename: G
authors.initials: G
authors.lastname: Gahrton
authors.forename: R
authors.initials: R
authors.lastname: Hast
authors.forename: A
authors.initials: A
authors.lastname: Killander
authors.forename: I
authors.initials: I
authors.lastname: Turesson
authors.forename: A M
authors.initials: AM
authors.lastname: Udén
authors.forename: O
authors.initials: O
authors.lastname: Vikrot
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D014182:Transplantation, Autologous
chemical_list: D007372:Interferons; D006918:Hydroxyurea